Semler Scientific, Inc. (NASDAQ: SMLR), a notable player in the healthcare sector, specializes in medical devices, with a focus on enhancing the efficiency and clinical effectiveness of healthcare providers in..
Autolus Therapeutics plc (NASDAQ: AUTL) is a burgeoning name in the biotechnology sector, primarily known for its innovative work in T cell therapies aimed at combating cancer and autoimmune diseases...
CeriBell, Inc. (CBLL), a burgeoning player in the healthcare sector, is capturing significant investor attention due to its promising potential upside of 156.85%. Specializing in medical devices, CeriBell is revolutionizing..
Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector specializing in medical devices, stands out with a remarkable potential upside of 54.98%. This potential increase, based on..
ATAI Life Sciences N.V. (NASDAQ: ATAI), a Germany-based biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to mental health treatments. With a market capitalization of..
Sage Therapeutics, Inc. (NASDAQ: SAGE) stands at a critical juncture within the competitive biotechnology sector. The company, headquartered in Cambridge, Massachusetts, is dedicated to developing innovative brain health medicines. Notably,..
Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical stage biopharmaceutical company based in South San Francisco, is emerging as a compelling player in the biotechnology sector. With a focus on developing..
Tourmaline Bio, Inc. (NASDAQ: TRML), a burgeoning player in the biotechnology sector, is captivating investor interest with its promising pipeline and remarkable growth potential. As a clinical-stage biotech firm, Tourmaline..
As the healthcare sector continues to evolve with innovative solutions, Treace Medical Concepts, Inc. (NASDAQ: TMCI) stands out with its specialized focus on medical devices. With a market capitalization of..
Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company based in New Haven, Connecticut, is capturing the attention of investors in the biotechnology sector. With a mission to develop innovative..
RxSight, Inc. (NASDAQ: RXST) is a medical device company at the forefront of innovation in the healthcare sector. With a focus on light adjustable intraocular lenses (LAL) for cataract surgery,..
Savara Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company making strides in the healthcare sector, is garnering attention from investors due to its potential for significant upside. With a current market..
Arvinas, Inc. (NASDAQ: ARVN), a biotechnology company based in New Haven, Connecticut, is attracting significant attention from investors looking to capitalize on its innovative approach to drug development and promising..
For investors intrigued by the intersection of biotechnology and mental health, COMPASS Pathways Plc (NASDAQ: CMPS) presents an intriguing opportunity. With a market capitalization of $413.51 million, this UK-based healthcare..
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is navigating the complex biotechnology landscape with a focus on developing innovative therapeutics for retinal diseases. With a market capitalization of approximately $799.56 million, EyePoint..
Investors with an eye on the biopharmaceutical sector might find Akebia Therapeutics, Inc. (NASDAQ: AKBA) a compelling opportunity, especially given its notable potential upside of 131.97%. This Cambridge, Massachusetts-based company..
Fortrea Holdings Inc. (FTRE), a prominent player in the biotechnology sector, is making waves with its strategic approach to contract research services. Headquartered in Durham, North Carolina, and incorporated in..
Septerna, Inc. (SEPN), a clinical-stage biotechnology company, is embarking on a promising journey within the healthcare sector, focusing on innovative treatments for various diseases through its development of G protein-coupled..
CureVac N.V. (NASDAQ: CVAC), headquartered in Tübingen, Germany, stands as a notable player in the biotechnology sector, specifically within the realm of healthcare. With a market capitalization of $1.22 billion,..
Keros Therapeutics, Inc. (NASDAQ: KROS) stands out in the biotechnology sector with a market capitalization of $616.14 million and a current stock price of $15.17. For investors looking at growth..
